Skip to main content
NSPR
NASDAQ Life Sciences

Q3 Revenue Falls 11% as Recall Wipes Out U.S. Sales; Cash Down to $19M

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.909
Mkt Cap
$35.983M
52W Low
$0.425
52W High
$2.22
52W Position info
114% above low
Off High info
59% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

NSPR has more than doubled off its 52-week low of $0.425 on elevated volume (2.4× avg).

Summary

Q3 revenue came in at $2.24M, down 11.1% from $2.52M a year ago, because U.S. sales collapsed to $32K from $497K after the May 2026 voluntary recall of the CGuard Prime CAS delivery system, though the revenue figure beat analyst estimates. Gross margin cratered to 10.7% from 34.2%, and the net loss was $9.76M, or $0.12 a share, versus $12.71M a year earlier — the smaller loss came from cutting operating expenses 26.7% to $10.19M, including $1.07M of restructuring tied to the workforce reduction. Cash and marketable securities fell to $19.25M from $54.21M at year-end, a burn rate that keeps the going-concern question front and center. The offset is the FDA approval of CGuard Prime for TCAR announced earlier today, which the company says adds over 35,000 procedures a year to its addressable market and should roughly double the U.S. opportunity, with U.S. sales starting in Q4 2026. Watch the 4:30 pm ET call today for launch timing and how they plan to fund the rollout, and the PMA supplement for the enhanced CAS delivery system targeted for December 2026.

At the time of this announcement, NSPR was trading at $0.91 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $36M. The 52-week trading range was $0.43 to $2.22. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NSPR - Latest Insights

NSPR
Nov 12, 2026, 5:24 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.6701
Real-time Price: $0.6518 info
Change: -$0.0183 (-3%) info
Market Cap: $35.983M info
NSPR
Nov 12, 2026, 4:45 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.650
Real-time Price: $0.6518 info
Change: +$0.0018 (+0.28%) info
Market Cap: $35.983M info
NSPR
Nov 12, 2026, 4:15 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.730
Real-time Price: $0.6518 info
Change: -$0.0782 (-11%) info
Market Cap: $35.983M info
NSPR
Nov 12, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.774
Real-time Price: $0.6518 info
Change: -$0.1222 (-16%) info
Market Cap: $35.983M info
NSPR
Sep 21, 2026, 9:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.770
Real-time Price: $0.6518 info
Change: -$0.1182 (-15%) info
Market Cap: $35.983M info